Bruker Daltonics Announces World's First Refrigerated 15 Tesla FTMS Magnet with New Tools for Top-down Protein Characterization.

SEATTLE -- At the 2006 ASMS conference, Bruker Daltonics today announces new tools to accelerate the detailed top-down characterization of proteins using the Company's apex(R)-Qe line of hybrid Fourier Transform mass spectrometers (Q-q-FTMS). These top-down tools include the world's first 15.0 Tesla (T) refrigerated (R-series) FTMS magnet, along with a novel and proprietary method of charge deconvolution, based on maximum entropy and an advanced monoistopic peak finder, called SNAP2(TM).

FTMS top-down methods of protein characterization are based on two key experimental capabilities: i) highly accurate molecular weight determination of the intact protein, and ii) fragmentation of the intact protein and analysis of the resulting complex mixture of fragments. Both benefit from FTMS detection with simultaneous high mass accuracy, high dynamic range and ultra-high resolution.

In large part, ultimate FTMS performance is governed by magnetic field strength. It is well documented that dynamic range, mass measurement accuracy, and mass resolving power improve dramatically with increasing magnetic field. The innovative actively-shielded 15.0T magnet, developed in collaboration with the affiliated Bruker BioSpin group, will enable researchers to investigate larger proteins by top-down analysis, while providing even better overall performance on an easy-to-use and easy-to-site platform.

The new 15T magnet is part of Bruker Daltonics' unique R-series of FTMS magnets that incorporate innovative cryostats equipped with cryocooler refrigeration that replaces the conventional liquid nitrogen reservoir. Besides a smaller footprint, R-series magnets require cryogens only once a year, and annual cryogen costs are minimal.

The unique geometry of the apex-Qe FTMS enables mass-selective efficient enrichment of low abundant protein species, which can then be investigated using a combination of fragmentation methods including CID, ECD, and/or IRMPD. The resulting complex mass spectra are feature-rich and have very high-information content on primary protein structure, as well as on important post-translational modifications. The intrinsic complexity of, for example, ECD spectra requires sophisticated data processing tools that can effectively extract mass information. To facilitate this, Bruker Daltonics has now implemented MaxEnt, a charge deconvolution method that is based on the popular Maximum Entropy algorithm, to calculate a neutral-based mass spectrum that is amenable to data analysis routines such as BioTools(TM). Moreover, by combining the ion signals represented by multiple charge states, MaxEnt also improves the fidelity of isotopic distributions and increases the overall spectral signal-to-noise ratio.

Another challenge associated with the processing of top-down data is the extraction of monoisotopic masses. Therefore, Bruker Daltonics has developed SNAP2, a new peak-picking module that accurately determines and extracts monoisotopic mass information from high-resolution spectra of proteins and protein fragments. The combination of these powerful new software features further strengthens the position of the apex-Qe as the preferred platform for detailed, ultra-high resolution top-down protein characterization.

"The ability to accurately extract monoisotopic peak information is crucial to analyzing feature-rich spectra from peptides and proteins. We are excited by the performance of the new SNAP2 algorithm and expect that it will significantly accelerate our biological MS efforts," said Dr. Jon Amster, Professor of Chemistry at the University of Georgia. The Amster Research Group in the Department of Chemistry uses a 9.4T apex-Qe in their laboratory for the investigation of complex biological samples.

ASMS 2006, the 54th American Society for Mass Spectrometry Conference will be held May 28 - June 1, 2006 in Seattle, Washington in the Washington State Convention & Trade Center.

ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical (NBC) detection products for defense and homeland security. Bruker AXS is a leading developer and provider of life science, materials research and industrial X-ray analysis tools. For more information about Bruker BioSciences Corporation, please visit www.bruker-biosciences.com

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the companies' reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the companies' products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K, our most recent quarterly reports on Form 10-Q, and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.